In vitro clot model to evaluate fibrin-thrombin effects on fractal dimension of incipient blood clot

Clinical Hemorheology and Microcirculation
Ahmed SabraPhillip A Evans

Abstract

This aim of this study is to investigate the individual effects of varying concentrations of thrombin and fibrinogen on clot microstructure (characterised through the fractal dimension of the incipient clot network, df) and clot formation time (TGP) using a fibrin-thrombin clot model. df and TGP markers are measured using a haemorheological method that has already been investigated for whole blood. This is an in vitro study using three thrombin concentrations (0.1, 0.05 and 0.02 NIH/ml) and two fibrinogen concentrations (8 mg/ml and 12 mg/ml) to investigate a fibrin-thrombin clot model. The haemorheological changes were measured at the gel point using df and TGP. Fractal dimension (df) increased with increasing concentrations of thrombin both at 8 mg/ml (1.60±0.024, 1.67±0.022, 1.74±0.079) and 12 mg/ml fibrinogen concentrations (1.63±0.02, 1.87±0.019, 1.95±0.014). On the other hand, TGP decreased for both 8 mg/ml (1089±265, 637±80, 223±22 seconds) and 12 mg/ml fibrinogen concentrations (2008±247, 776±20, 410±20 seconds). In contrast to previous studies investigating whole blood, TGP increased with higher fibrinogen levels. The findings from this fibrin-thrombin clot model confirmed that df and TGP can detect changes in the inci...Continue Reading

References

Feb 15, 1990·Physical Review. a·M Y LinP Meakin
Nov 5, 1999·Biophysical Journal·E A RyanL Lorand
Dec 2, 2004·Biophysical Chemistry·Harold A Scheraga
Jan 12, 2013·Blood·John W Weisel, Rustem I Litvinov
Oct 11, 2014·British Journal of Haematology·Matthew J LawrencePhillip A Evans
Aug 22, 2015·Thrombosis and Haemostasis·Nia Anne DaviesPhillip Adrian Evans
Aug 2, 2017·Open Heart·Ahmed SabraPhillip Adrian Evans

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.